Dr Chacko Joseph has international experience in R&D and commercialisation of life science technologies.
He is part of the life sciences commercialisation team at Monash University, responsible for commercialising an extensive portfolio of technologies. He is also the head of corporate and business development at oNKo-Innate, a private immuno-oncology company. He was part of Altnia Operations, a privately-held biotechnology incubator and life sciences R&D company, where he co-invented the core technology that formed the basis of the ASX-listed company Exopharm.
Chacko has managed life science-related translational research projects in the USA, Belgium and India. Dr Joseph holds a PhD in Medicine from University of Melbourne and Bachelor in Engineering from M.G.R University Chennai, India.